About BMJ Group media relations team (Emma Dickinson, Caroline White, and Erin Barton)

Our media relations team connects journalists with expert insights and the latest research to support accurate, evidence based healthcare reporting. They manage media interviews, press releases, media inquiries, and publicise key findings from the Group's journals, tools, and services. Contact: mediarelations@bmj.com or +44 (0)7825 118 107

Resistance exercise ‘activity breaks’ at night may improve sleep length

3-minute breaks every half hour for 4 hours may be all that’s needed, small study suggests May be worth reviewing current recommendations which discourage exercise before bed Resistance exercise ‘activity breaks’ at night may improve sleep length, suggest the findings of a small comparative study published in the open access ...

Active commuting linked to lower risks of mental and physical ill health

Strongest benefits seen for cyclists, with 47% lower risk of death from any cause Commuters who cycle or walk to and from work or study may have lower risks of mental and physical ill health than those who don’t rely on these options, finds a large long term study published ...

2024-07-17T15:10:58+00:0017 July 2024|BMJ Public Health, Press release|

Few UK people likely to be suitable for new Alzheimer’s drugs when they come on stream

But many people with memory loss nevertheless likely to be referred for these treatments Few people in the UK with early stage Alzheimer’s disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred for ...

Rise in global number of patient harms from 11 million to 18 million (59%) in 30 years

Outpacing 45% increase in world’s population during the same period (1990-2019) Older people worldwide bear the brunt, with steepest rise among 65-69 year olds  The proportion of patient harms associated with medical procedures, treatment, and contact with healthcare systems rose by 59%, from 11 million to 18 million globally between ...

2024-07-31T17:40:28+00:0012 July 2024|BMJ Quality & Safety, Press release|

Revealed: tricks used by opioid giant to mould doctors’ minds

Experts find “smorgasbord of tactics” used to boost sales during opioid addiction epidemic Opioid giant Mallinckrodt, selling more than Purdue Pharma in the US, was forced by the courts to publish more than 1.3 million internal documents. In The BMJ today, researchers Sergio Sismondo and Maud Bernisson sift through nearly 900 contracts ...

2024-07-31T17:39:17+00:0011 July 2024|Press release, The BMJ|

World leaders unite to embed social participation in health systems

Landmark WHO resolution marks an important step towards a healthy world For the first time in the World Health Organization’s 76 year history, world leaders have unanimously committed to put social participation - people, communities and civil society - at the heart of health decision making processes. This landmark pledge ...

2024-08-01T08:53:14+00:009 July 2024|Press release, The BMJ|

NHS’s relentless focus on finance and productivity is failing patient safety

Patients’ concerns too often go ignored, says England’s first patient safety commissioner “The NHS’s relentless focus on finance and productivity is failing patient safety,” argues patient safety commissioner Henrietta Hughes in an interview for The BMJ today. “The patient’s anecdote is the canary in the coal mine,” she says. It’s the thing ...

2024-08-01T08:51:20+00:009 July 2024|Press release, The BMJ|

Intensive voice treatment more effective than NHS speech therapy for Parkinson’s disease

Results highlight need to optimise speech therapy resources, say researchers An intensive voice treatment developed in the USA and known as the Lee Silverman voice treatment (LSVT LOUD) is more effective than conventional NHS speech and language therapy or no therapy for people with Parkinson’s disease, finds a trial published ...

2024-08-01T08:49:31+00:009 July 2024|Press release, The BMJ|

FDA staff leaving for industry jobs given “behind the scenes” lobbying advice

Practice highlights “critical loophole” in the revolving door between the FDA and industry The US Food and Drug Administration (FDA) tells staff leaving for industry jobs that, despite restrictions on post-employment lobbying, they are still permitted to influence the agency, reveals an investigation by The BMJ today. Internal emails, obtained under a ...

2024-07-02T15:12:11+00:002 July 2024|Press release, The BMJ|

Poorer teen mental ability linked to as much as tripling in stroke risk before age of 50

Associations held after factoring in diabetes and limiting age of first stroke up to 40 Assessments beyond traditional stroke risk factors now needed, suggest researchers A lower level of mental ability during the teenage years may be linked to as much as a tripling in the risk of having a ...

Go to Top